Category: FirstinHuman
-
CARsgen Presents First-in-human Results of GPRC5D Targeting CAR-T CT071 at EHA 2024 By Investing.com
•
Shanghai, June 15, 2024 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (ticker symbol: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematological malignancies and solid tumors, announces that preliminary results from the ongoing first-in-human study of CT071 have been presented at the conference. The twenty-ninth annual…
-
JJP Biologics Announces Positive Decision to Execute a First-in-Human Clinical Trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89)
•
This section is Partnership content provided The content in this section is provided by Business Wire for the purposes of press release distribution on behalf of its clients. Postmedia has not reviewed the content. by Business wire Breadcrumb links PMN press releases Business newsletters Article writer: Posted on May 29,…